Nothing about us without us: ‘patients-as-partners’ model shows promise for improving HIV care
Caribbean programme that formed partnerships between healthcare providers and people with HIV significantly improved HIV care
Caribbean programme that formed partnerships between healthcare providers and people with HIV significantly improved HIV care
HIV prevalence is three times higher among men who have sex with men in African countries that criminalise homosexuality compared to those that don’t
District-level data from 40 African countries reveal significant differences in HIV prevalence by age and sex
Women who sell sex in Nsanje, Malawi show a high-level of engagement with HIV treatment due to the existence of peer-led services
Findings from Zambia from the first ever PrEP study in prisons – in Africa or anywhere – has reported uptake of 93%
South African study finds 90% of people with HIV referred through a community-based scheme completed preventative TB treatment – 11% more than people in standard HIV care
Modelling from sub-Saharan Africa suggests male circumcision should continue for the next five years at least, despite increased access to HIV treatment and PrEP
A number of African countries have now approved a vaginal ring that contains the antiretroviral drug dapivirine, which women can use to stop themselves from getting HIV.
From breakthroughs on HIV prevention to a global monkeypox outbreak and the continuing fallout of COVID-19, this has been a year of highs and lows. We look back on five of the most significant moments
More choice for HIV prevention could be on the horizon after Uganda approves injectable PrEP and a PrEP vaginal ring
Country will make injectable HIV treatment available from next year
UNAIDS’ latest data shows progress on HIV prevention and treatment has stalled, putting millions of people in danger
A global report on harm reduction for people who use drugs finds services have increased but funding is shrinking
We’re kick-starting open and honest conversations on sexual health and HIV. Are you in?
A pilot offering injectable PrEP to adolescent girls and young women is due to start next year
Dolutegravir is more effective than other antiretroviral drugs at getting HIV back under control if someone’s viral load rises